Diabetic Peripheral Neuropathy

What Is Painful Diabetic Peripheral Neuropathy (PDPN)? 

Painful diabetic peripheral neuropathy (PDPN) is a common complication of diabetes, characterized by damage to the peripheral nerves, leading to chronic pain, burning sensations, tingling, numbness, and sensory discomfort, most often in the feet and hands. This pain is typically described as burning, stabbing, or shooting, and often worsens at night, significantly affecting sleep, mobility, and quality of life.

Key Distinguishing Symptoms

• Chronic burning, stabbing, or electric shock–like pain: The pain in PDPN is persistent and often described as burning, tingling, lancinating, or shooting, worse at night, and may be accompanied by numbness or pins-and-needles sensations.
• Allodynia and hyperalgesia: Many patients experience pain from normally non-painful stimuli (allodynia, e.g., pain from light touch or bedsheets) or exaggerated pain responses to mild stimuli (hyperalgesia).
• Stocking-glove distribution: Symptoms usually begin in the toes and feet, sometimes affecting hands later, and progress up the legs in a symmetrical “stocking” pattern, unlike mononeuropathies that follow isolated nerve distributions.

What Is PDPN?

Painful diabetic peripheral neuropathy (PDPN) is a common complication of both type 1 and type 2 diabetes, affecting up to 30% of individuals with diabetic peripheral neuropathy. It occurs when high blood sugar causes damage to the nerves in the arms, legs, hands, or feet—most often in a “stocking-and-glove” pattern starting at the toes and fingers. This damage leads to chronic, often severe, nerve pain and other sensory disturbances that can significantly impact daily life.

Causes

• Long-term high blood sugar is the main cause of nerve fiber injury in diabetes, but other risk factors include older age, high blood pressure, obesity, high cholesterol, and smoking.
• Nerve energy failure plays a key role: diabetes disrupts normal cell energy supply, causing nerve dysfunction—especially in nerves far from the spinal cord, such as those in the feet.
• Additional contributors: Certain medications (like chemotherapy), vitamin B12 deficiency, kidney disease, alcohol misuse, or autoimmune conditions can worsen symptoms or mimic PDPN, so clinicians rule out other causes as part of the work-up.

Key Distinguishing Symptoms

• Chronic burning, stabbing, or electric shock–like pain: The pain in PDPN is persistent and often described as burning, tingling, lancinating, or shooting, worse at night, and may be accompanied by numbness or pins-and-needles sensations.
• Allodynia and hyperalgesia: Many patients experience pain from normally non-painful stimuli (allodynia, e.g., pain from light touch or bedsheets) or exaggerated pain responses to mild stimuli (hyperalgesia).
• Stocking-glove distribution: Symptoms usually begin in the toes and feet, sometimes affecting hands later, and progress up the legs in a symmetrical “stocking” pattern, unlike mononeuropathies that follow isolated nerve distributions.

How Is PDPN Diagnosed?

Diagnosis relies on:

• Thorough medical history and review of diabetes status, risk factors, and symptoms.
• Focused neurological exam checking for sensory loss, reduced vibration sense (using a tuning fork), pinprick or temperature sensation, and diminished ankle reflexes—all starting at the toes and moving upward in both feet. These tests typically show a symmetrical, distal-to-proximal pattern.
• Symptom questionnaires or pain scales for standardized assessment (e.g., DN4 or Visual Analog Scale).
• Screening for other causes of neuropathy (e.g., vitamin B12 deficiency, thyroid disease, kidney dysfunction) and ruling out conditions like peripheral arterial disease or radiculopathy. 
• Nerve conduction studies are rarely required unless the presentation is atypical.

Treatment Options

Non-Drug Approaches:

• Blood sugar optimization: Achieving and maintaining stable blood glucose is essential but may not reverse established neuropathic pain.
• Lifestyle:
  • Regular physical activity and dietary improvement have some preventive and symptom-modifying benefits.
  • Smoking cessation and treating hypertension or high cholesterol are recommended.
• Multidisciplinary support: Addressing psychological factors, sleep, and overall wellbeing is crucial.

Medications:

• First-line options (FDA-approved):
  • Pregabalin and duloxetine—these target nerve pain and can be given alone or together.
  • Gabapentin and amitriptyline—also commonly used, particularly if first-line agents are not tolerated.
• Second-line or adjunctive options:
  • Topical capsaicin 8% patch for localized neuropathic pain.
  • Opioids (e.g., tapentadol) are generally not recommended due to risk of dependence and side effects.
• Other options: Vitamin and nutraceutical supplementation may be considered as supportive therapy, but strong evidence is limited.

Special Considerations

• Elderly patients may be more prone to medication side effects and gait disturbances. Close monitoring and dose adjustment, along with balance and fall prevention efforts, are vital.

Advanced and Adjunct Therapies:

High-frequency (10 kHz) spinal cord stimulation (HFX SCS) is one of the most effective options for patients with painful diabetic neuropathy when medications and conservative treatments are not enough.

• Supported by leading guidelines: The American Diabetes Association, German Diabetes Association, German Interdisciplinary Association for Pain Therapy, and an international consensus in 2021 all recommend spinal cord stimulation—and specifically high-frequency (10 kHz) therapy—as a treatment for painful diabetic neuropathy.
• Strong clinical results: In studies, about 85% of patients achieved at least 50% pain relief, with many experiencing meaningful improvements in lower-limb pain.
• Beyond pain relief: Patients also reported better sensation, less numbness, and improved ability to walk and function day to day.
• Modern therapy without side effects of older systems: Unlike older, low-frequency stimulators that produce a tingling or buzzing sensation, HFX SCS provides paresthesia-free pain relief. It also offers an alternative to long-term opioid therapy, avoiding the risks of medication dependence.

When to Screen for Peripheral Arterial Disease (PAD)

People with diabetes are at higher risk for both nerve damage (PDPN) and poor circulation (PAD). These two conditions can overlap, and their symptoms may feel similar.

• Why it matters: Pain from PAD—called ischemic pain—can mimic nerve pain from PDPN. Both may cause burning, cramping, or aching in the feet and legs, but the underlying problems are different:
  
  • PDPN comes from damaged nerves, leading to burning pain, tingling, numbness, and sensitivity.
  • PAD comes from blocked or narrowed arteries, leading to reduced blood flow, leg cramps with walking, cold feet, slow-healing wounds, and in severe cases, pain even at rest.
• Coexistence is common: Many patients with diabetes have both PDPN and PAD. If PAD is missed, patients remain at higher risk for ulcers, infections, and even amputation.

Screening is simple and noninvasive:

• Checking pulses in the feet and ankles
• Measuring blood flow with an ankle-brachial index (ABI) or, if arteries are calcified, a toe-brachial index (TBI)
  
• Performing vascular ultrasound when symptoms suggest poor circulation

Why screening is essential:

Distinguishing neuropathic pain from ischemic pain ensures patients receive the right treatment—whether that means nerve-focused therapy, circulation-focused intervention, or both. Early detection of PAD prevents complications, protects the limb, and improves quality of life.